tamoxifen and glp 1 SABCS 2025: Can GLP-1s Help People With Breast Cancer? GLP-1s in Oncology: Nursing Insights

How the US GLP-1 Landscape Changed in 2026 Three structural shifts redefined the market between 2024 and 2026

FDA-approved medications in this class are available

2025 Case report describes female sexual dysfunction temporally associated with GLP-1 agonists including semaglutide (hypothesis-generating mechanism)

Non-peptide agonists like geniposide show oral bioavailability, broadening therapeutic potential [33]

Awareness of the Wegovy pill remains relatively low Despite growing media attention around weight loss tablets, just 18.35% of respondents said they were aware that a tablet version of Wegovy is expected to become available in the UK in 2026